GE HealthCare Technologies Inc.
GEHCQ3 2023(GEHC Q2 FY2023)Estimated2% AI
AI Revenue %
2%
AI Fair Value
$354.0M
AI Revenue (Q)
$96.3M
Total Revenue (Q)
$4.8B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
Q2 2023 total revenue $4,817M (Products $3,213M + Services $1,604M). No AI revenue breakout. Same four-segment structure with no AI sub-segment reporting. The company continues to describe AI capabilities within its product descriptions but provides zero dollar quantification of AI-specific revenue. Conservative 2% estimate maintained. Math: ~$96M estimated AI / $4,817M total = ~2.0%.
Analyzed by claude-opus-4-6
Quoted Figures
Total revenues $4,817M (Q2 2023), Products $3,213M, Services $1,604M
10-Q 2023-06-30, Income Statement
Research and development $298M
10-Q 2023-06-30, Income Statement
AI Products Identified (Ring 1)
Edison AI platformCT Air Recon DLMR AIR Recon DLAI-enabled clinical applications
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Imaging segment equipmentUltrasound devicesPCS monitoring systemsPDx contrast agentsService contracts
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix